Adjuvant Endocrine Therapy for Premenopausal Women With Early Breast Cancer
- 10 March 2005
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (8) , 1736-1750
- https://doi.org/10.1200/jco.2005.11.050
Abstract
No abstract availableThis publication has 78 references indexed in Scilit:
- Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: A critical review of the literatureInternational Journal of Cancer, 2004
- A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast CancerNew England Journal of Medicine, 2004
- A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast CancerNew England Journal of Medicine, 2003
- Survival analyses from the ZEBRA studyEuropean Journal Of Cancer, 2003
- Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer Co-operative Group DBCG 82B trialEuropean Journal Of Cancer, 1999
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- PP-5-6 Castration and Tamoxifen Versus Chemotherapy (FAC) for Premenopausal, Node and Receptors Positive Breast Cancer Patients: A Randomized Trial with a 7 Years Median Follow UpEuropean Journal Of Cancer, 1996
- Tamoxifen resistance in breast cancerCritical Reviews in Oncology/Hematology, 1993
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896